|Bid||1.9000 x 1000|
|Ask||1.9200 x 1200|
|Day's Range||1.8700 - 1.9426|
|52 Week Range||1.2500 - 8.8800|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for JUPWLearn more
JUPITER, FL / ACCESSWIRE / October 19, 2021 /Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced the enrollment and dosing of the first patient in the study.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Volt Information Sciences The Trade: Volt Information Sciences, Inc. (NYSE: VOLT) Director Arnold Ursaner bought a total o
JUPITER, FL / ACCESSWIRE / October 7, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today provided an update on its advancing clinical programs and commercial progress.